Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
The SECURE 340B Act strengthens oversight of the federal 340B drug discount program, which allows certain hospitals and health centers to purchase medications at reduced prices for low-income patients. The bill establishes stricter eligibility rules requiring patients to have received care from participating facilities within 24 months and prescribers to be employed by or contracted with those facilities, while creating new enforcement mechanisms including penalties for entities exceeding 35% of referral prescriptions annually. It imposes detailed requirements on contract pharmacies, subsidiary locations ("child sites"), and manufacturers, mandates transparent financial assistance policies and medical debt restrictions for participating hospitals, and creates a federal data clearinghouse to prevent duplicate discounts and improve program integrity. The bill also requires participating entities to report detailed annual data on patients served and drug savings to the Department of Health and Human Services for public disclosure, while prohibiting health plans and pharmacy benefit managers from discriminating against 340B participants. Most provisions take effect immediately upon enactment, with the Secretary required to issue implementing regulations within 180 days and covered entities given a minimum 180-day transition period to comply.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.